
Diabeloop wins FDA nod for new automated insulin delivery algorithm
Diabeloop announced today that its DBLG2 algorithm for automated insulin delivery has received FDA 510(k) clearanc

Diabeloop announced today that its DBLG2 algorithm for automated insulin delivery has received FDA 510(k) clearanc

Stifel analysts said the label for cardiac myosin inhibitor Myqorzo is in line with their expectations and is differentiated compared with BMS’ Camzyos.

Abbott (NYSE: ABT)+
announced today that the FDA approved its Volt pulsed field ablation (PFA) system to treat patients with AFib.

Scientists at Duke-NUS Medical School have developed two powerful computational tools that could transform how researchers study the “conversations” between cells inside the body. The tools, called sCCIgen and QuadST, help scientists understand both where cells are located in tissues and how they communicate through genetic activity and chemical signals.

Cancer is one of the leading causes of death in the U.S., second only to heart disease. But a new cancer treatment method from CU Boulder researchers uses sound waves to soften tumors and could be a potent tool against the disease.

Craif Inc. in Nagoya, Japan, working with Nagoya University’s Institute of Innovation for Future Society, has developed a urine-based biological aging clock. In validation of the method, predicted ages came within 4.4 years of chronological age on average.